The city of San Francisco reported an increase of 4.3% in the number of new cases of HIV diagnosed last year. That’s a rise ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Stigma and lack of support hinder PrEP use among Black women; clinician bias and discrimination worsen disparities.

A new survey launched by Global Black Gay Men Connect is seeking responses from Black gay men and Black trans community ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...

Patrick Sullivan, DVM, PhD, an infectious disease epidemiologist and professor of epidemiology at Emory University in Atlanta, Georgia, spoke about his recent analysis that revealed that modest ...

Lenacapavir, developed by Gilead Sciences and approved earlier this year for HIV prevention under the brand name Yeztugo, is ...

The short film, produced by Oscar-nominated writer and ‘Fellow Travelers’ creator Ron Nyswaner, also features Thuso Mbedu. The UNAIDS project premiered Monday at a United Nations assembly in New York.

Prince Harry's aides have denied that his latest HIV campaign film was aimed at Donald Trump, after the Duke of Sussex warned millions could die as a result of international funding cuts. In a ...

Funding cuts are affecting countries with high HIV rates by creating shortages of community health workers and data ...